Cenrifki prevents MS disease progression and Itvisma delivers a healthy gene-to-cell nuclei, addressing the root cause of SMA.
If approved, Itvisma (intrathecal onasemnogene abeparvovec) will be first and only gene replacement therapy for children two ...
Late-Breaking Oral Presentation Intravenous delivery of VY1706, a CNS penetrant AAV gene therapy for Alzheimer’s disease, ...
One reason these wellness practices are popular is because they’re powerful and they remake us,” says religious ethicist ...
Discover 25 incredible facts about the human body that will blow your mind! From neurogenesis to daily height changes, ...
The wombat’s intestine does something no other gut on Earth does. Understanding why reveals how deeply evolution can sculpt ...
4dOpinion
Human in the Loop
It won’t do to just crib and critique. We are as good as our vote, says author ...
If approved, Itvisma (intrathecal onasemnogene?abeparvovec) will be first and only gene replacement therapy for children two years and older, teens and adults with SMA in the European UnionItvisma dem ...
That is because scientists keen to achieve more precise control over an organism’s genetics are experimenting with a ...
The American College of Sports Medicine released new guidelines this year to help doctors prescribe resistance exercise. Here ...
After a series of regulatory and clinical setbacks for Sanofi’s tolebrutinib, the French pharma has scored a victory for the ...
Nature never ceases to amaze, but some of its tiniest inhabitants are capable of incredible things. An example of this would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results